LNSR Stock Overview
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism.
LENSAR, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$6.28|
|52 Week High||US$8.98|
|52 Week Low||US$5.50|
|1 Month Change||-10.29%|
|3 Month Change||-8.05%|
|1 Year Change||-24.20%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-30.22%|
Recent News & Updates
LENSAR GAAP EPS of -$0.67, revenue of $8M
LENSAR press release (NASDAQ:LNSR): Q2 GAAP EPS of -$0.67. Revenue of $8M (+1.3% Y/Y). Adjusted EBITDA was -$4.3M for the quarter ended June 30, 2022 and -$2.3M for the quarter ended June 30, 2021. As of June 30, 2022, the company had cash and cash equivalents of $25.2M as compared to $31.6M at December 31, 2021. Based on its cash position and operational forecasts, the company believes it has sufficient cash to fund operations into 2024.
|LNSR||US Medical Equipment||US Market|
Return vs Industry: LNSR underperformed the US Medical Equipment industry which returned -21.3% over the past year.
Return vs Market: LNSR underperformed the US Market which returned -13% over the past year.
|LNSR Average Weekly Movement||4.6%|
|Medical Equipment Industry Average Movement||9.6%|
|Market Average Movement||7.9%|
|10% most volatile stocks in US Market||17.2%|
|10% least volatile stocks in US Market||3.2%|
Stable Share Price: LNSR is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: LNSR's weekly volatility (5%) has been stable over the past year.
About the Company
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
LENSAR, Inc. Fundamentals Summary
|LNSR fundamental statistics|
Is LNSR overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|LNSR income statement (TTM)|
|Cost of Revenue||US$17.81m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-2.13|
|Net Profit Margin||-63.71%|
How did LNSR perform over the long term?See historical performance and comparison